| Sources | Names Used |
|---|---|
| CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
| PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UBTF | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-08 |
| mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | SMARCC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | PLA2G15 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | RTFDC1 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | SAFB2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
